Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 42

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 42
---
8-K that disclosed material nonpublic information. 24

TABLE OF CONTENTS

DIRECTOR COMPENSATION Our Board believes that the level of director compensation should be based on time spent carrying out Board and committee responsibilities and be competitive with comparable companies. In addition, the Board believes that a significant portion of director compensation should align director interests with the long-term interests of stockholders. The Board makes changes in its director compensation practices upon the recommendation of the Compensation Committee and following discussion and approval by the Board. Our Board, following the Compensation Committee’s recommendation, approved the 2024 compensation of our non-employee directors, as described below. The compensation level of our non-employee directors is expected to remain the same in 2025.

|                                               |     | Annual Service 
       Retainer 
            ($) |     |         Chairperson 
 Additional Retainer 
                 ($) |
| Board of Directors                            |     |         40,000 |     |              37,500 |
| Audit Committee                               |     |          7,500 |     |              27,500 |
| Compensation Committee                        |     |          5,000 |     |              15,000 |
| Nominating and Corporate Governance Committee |     |          5,000 |     |              10,000 |

On February 22, 2024, each non-employee director was awarded a grant of options for 2,250 shares as equity compensation and on September 11, 2024 awarded a grant of options for 3,650 shares as equity compensation. The following table summarizes director compensation awarded to, earned by or paid to our non-employee directors who served on our Board during fiscal year 2024:

| Non-Executive Director Name(1) |     | Fees Earned 
  or Paid in 
        Cash 
         ($) |     |    Option 
    Awards 
 ($)(2)(3) |     |   Total 
     ($) |
| Richard J. Hawkins, Chairman   |     |      95,000 |     |     9,167 |     | 104,167 |
| Howard Clowes                  |     |      67,500 |     |     9,167 |     |  76,667 |
| An van Es-Johansson, M.D.      |     |      57,500 |     |     9,167 |     |  66,667 |
| Robert Lenk, PhD               |     |      45